Evidence map›Paper›PMID 36901930›Full record

ArticleInternational journal of molecular sciences2023

Estrogen Receptor-β Gene Cytosine-Adenine (

Naoko Honma, Tomio Arai, Yoko Matsuda, Yosuke Fukunaga, Masaaki Muramatsu, Shinobu Ikeda, Yuri Akishima-Fukasawa, Noriko Yamamoto, Hiroshi Kawachi, Yuichi Ishikawa and 2 more

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. 17β-estradiol in colorectal cancer: friend or foe?Cell communication and signaling : CCS · 2024
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Naoko HonmaDepartment of Pathology, Faculty of Medicine, Toho University, Omori-Nishi, Ota-ku, Tokyo 143-8540, Japan.
Tomio AraiDepartment of Pathology, Tokyo Metropolitan Geriatric Hospital, Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan.
Yoko MatsudaDepartment of Pathology, Tokyo Metropolitan Geriatric Hospital, Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan.ORCID 0000-0002-3235-655X
Yosuke FukunagaGastroenterological Center, Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo 135-8550, Japan.
Masaaki MuramatsuDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Shinobu IkedaJapan Agency for Medical Research and Development, Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan.
Yuri Akishima-FukasawaDepartment of Pathology, Faculty of Medicine, Toho University, Omori-Nishi, Ota-ku, Tokyo 143-8540, Japan.
Noriko YamamotoDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo 135-8550, Japan.
Hiroshi KawachiDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo 135-8550, Japan.ORCID 0000-0002-8270-791X
Yuichi IshikawaDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo 135-8550, Japan.
Kengo TakeuchiDivision of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo 135-8550, Japan.ORCID 0000-0002-1599-5800
Tetuo MikamiDepartment of Pathology, Faculty of Medicine, Toho University, Omori-Nishi, Ota-ku, Tokyo 143-8540, Japan.
Japanese Foundation For Cancer Research · JPToho University · JPJapan Agency for Medical Research and Development · JPJuntendo University · JPKagawa University · JPTokyo Metropolitan Geriatric Hospital · JP

Funding

Ministry of Education, Culture, Sports, Science and Technology 21K06932Ministry of Education, Culture, Sports, Science and Technology 25460429
6 · The paper itself

Abstract

The pathobiological role of estrogen is controversial in colorectal cancer. Cytosine-adenine (CA) repeat in the estrogen receptor (ER)-β gene (

Indexed as

Colonic NeoplasmsReceptors, EstrogenAdenineAgedCytosineEstrogen Receptor betaFemaleHumansPostmenopauseAdenineCytosineESR2 protein, humanEstrogen Receptor betaReceptors, Estrogenagecolon cancerESR2-CA repeat polymorphismestrogenestrogen receptor-βmismatch repair proteinpostmenopausal women

Identifiers

PMID36901930
PMCPMC10003297
OpenAlexW4322501554

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.